BlackRock
LHDX

BlackRock’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

BlackRock’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-53,206
Closed -$5.91K – 5787
2022
Q4 		$5.91K Buy
53,206
+920
+2% +$587 ﹤0.01% 5509
2022
Q3 		$56K Sell
52,286
-1,150
-2% -$2.62K ﹤0.01% 5334
2022
Q2 		$99K Buy
53,436
+1,968
+4% +$4.78K ﹤0.01% 5242
2022
Q1 		$183K Buy
51,468
+8,131
+19% +$39.9K ﹤0.01% 5125
2021
Q4 		$373K Sell
43,337
-10,824
-20% -$68.8K ﹤0.01% 4960
2021
Q3 		$412K Buy
54,161
+25,913
+92% +$219K ﹤0.01% 4814
2021
Q2 		$187K Sell
28,248
-441,267
-94% -$2.78M ﹤0.01% 4905
2021
Q1 		$5.68M Buy
+469,515
New +$9.31M ﹤0.01% 3885

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $2.57B AUM
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
RA
Resolute Advisors San Francisco, California $417M AUM 60.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

BlackRock's LHDX Position: Q1 2023 in Review

BlackRock sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 53,206 shares — an estimated $5.91K sold.

BlackRock first reported a position in LHDX in Q1 2021 and held it in 8 quarters. The position peaked at $5.68M in Q1 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

  • BlackRock reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • BlackRock sold 53,206 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $5.91K.
  • BlackRock first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • BlackRock's Lucira Health, Inc. Common Stock position peaked at $5.68M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on BlackRock's 13F filing for Q1 2023, filed 12 May 2023.